FDA clears 3D Computed Tomography for use in Varian's On-Board Imager
This article was originally published in Clinica
Varian Medical Systems has received FDA 510(k) clearance to mount 3D imaging capabilities onto its series of linear accelerated radiation therapy devices. Named cone-beam CT imaging, the technology has already proved to be effective in the company's Acuity range of radiation treatments. It will be implemented on Varian's On-Board Imager, used by doctors to administer real-time image guided radiation therapy (IGRT).
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.